France launches major genetic screening test for 5,000 newborns

NCT ID NCT06875089

Summary

This study is testing a new method of screening newborns for rare genetic diseases using advanced DNA sequencing. It will enroll 5,000 newborns across five French hospitals to see if this screening process is practical, fast, and acceptable to parents. The goal is to gather information to help decide if this type of genetic screening should be used more widely in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEWBORN SCREENING PROGRAMMES FOR RARE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Besançon

    NOT_YET_RECRUITING

    Besançon, 25000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Dijon Bourgogne

    RECRUITING

    Dijon, 21000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Hôtel Dieu

    NOT_YET_RECRUITING

    Nantes, 44093, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Rennes - Hôpital Sud

    NOT_YET_RECRUITING

    Rennes, 35203, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU d'Angers

    NOT_YET_RECRUITING

    Angers, 49933, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.